These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3561813)

  • 1. [Therapeutic effectiveness of isosorbide-5-mono nitrate in the treatment of exertion myocardial ischemia].
    Cassottana P; Torre F; Bafico GL; Oddone D; Vinci P; Gatto R; Borgo E
    Minerva Cardioangiol; 1987; 35(1-2):79-82. PubMed ID: 3561813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
    Isbary J; Doering W; Wauer B; Greding H; König E
    Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isosorbide mononitrate or dinitrate in coronary disease?].
    Schanzenbächer P; Kochsiek K
    Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Elantan in coronary heart disease. Report of experiences].
    Jahed M
    ZFA (Stuttgart); 1983 Aug; 59(22):1234-5. PubMed ID: 6624210
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
    Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
    Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of isosorbide dinitrate of prolonged action on the prevention of myocardial ischemia induced by exercise: correlation with nitrate blood levels].
    Duprat R; Meneghelo RS; Batlouni M; Hoxter G
    Arq Bras Cardiol; 1975 Jun; 28(3):369-77. PubMed ID: 1180718
    [No Abstract]   [Full Text] [Related]  

  • 8. [Higher therapeutic safety of Mono-Nitrate. Report on the 3rd Mono-Nitrate Workshop of the Pharma-Schwarz Company, Monheim].
    Fortschr Med; 1984 May; 102(20):70-1. PubMed ID: 6735340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
    Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
    Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
    Müller G; Schmidt-Voigt J
    Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 17. Isosorbide dinitrate-induced improvement in left ventricular ejection fraction during exercise in coronary arterial disease.
    Steele PP; Rainwater J; Jensen D; Vogel RA; Battock D
    Chest; 1978 Nov; 74(5):526-30. PubMed ID: 738090
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
    Schuster P; Trieb G; Wiechmann HW
    Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.